RLN2 and hypertensive disorder: It has been described that relaxin-2 levels are significantly lower in patients with hypertension and/or with masked hypertension (frequently associated with higher risk for target organ damage, increased hazard for essential hypertension, and cardiovascular morbidity similar to hypertensive patients) compared with normotensives individuals (Table 4) [130,133].